Shionogi (FRA:SH0) Net Income From Continuing Operations : €1,113 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Shionogi Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shionogi's net income from continuing operations for the three months ended in Mar. 2024 was €208 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was €1,113 Mil.

Shionogi Net Income From Continuing Operations Historical Data

The historical data trend for Shionogi's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Net Income From Continuing Operations Chart

Shionogi Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

1,332.41

1,105.21

966.89

1,539.60

1,217.61

Shionogi Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Income From Continuing Operations	Get a 7-Day Free Trial															363.72	379.62	311.34	207.53	214.95

Shionogi Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,113 Mil.

Shionogi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (FRA:SH0) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

SGIOY:USA SGIOF:USA 4507:Japan SH0:Germany

Address

1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045

Website

http://www.shionogi.co.jp

Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi Headlines

No Headlines